Long-term efficacy of inhaled N-acetylcysteine in patients with idiopathic pulmonary fibrosis

Internal Medicine

Volumn 49, Issue 21, 2010, Pages 2289-2296

  Bando, Masashi ^a   Hosono, Tatsuya ^a   Mato, Naoko ^a   Nakaya, Takakiyo ^a   Yamasawa, Hideaki ^a   Ohno, Shoji ^b   Sugiyama, Yukihiko ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b International University of Health and Welfare Hospital   (Japan)

Author keywords

Idiopathic pulmonary fibrosis; Inhalation; N acetylcysteine (NAC)

Indexed keywords

ACETYLCYSTEINE;

ADULT; APPETITE DISORDER; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; COUGHING; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; DRUG WITHDRAWAL; DYSPNEA; FEMALE; FIBROSING ALVEOLITIS; HUMAN; LONG TERM CARE; LUNG FUNCTION TEST; MALE; MONOTHERAPY; OXYGEN THERAPY; RETROSPECTIVE STUDY; SMELLING DISORDER; SULFUR SMELL DISORDER; SURVIVAL RATE; TREATMENT DURATION;

ACETYLCYSTEINE; ADMINISTRATION, INHALATION; AGED; CASE-CONTROL STUDIES; FEMALE; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; MALE; MIDDLE AGED; RESPIRATORY FUNCTION TESTS; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 78249269126     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.49.4011     Document Type: Article

References (17)

1. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 161: 646-664, 2000.
2. King TE Jr, Tooza JA, Schwarz MI, Brown KR, Cherniack RM. Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. Am J Respir Crit Care Med 164: 1171- 1181, 2001.
3. Demedts M, Behr J, Buhl R, et al. High-dose acetylcysteine in idiopathic pulmoanry fibrosis. N Engl J Med 353: 2229-2242, 2005.
4. Azuma A, Nukiwa T, Tsuboi E, et al. Double-blind placebocontrolled trial of pirfenidone in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 171: 1040-1047, 2005.
5. Raghu G, Lasky JA, Costabel U, et al. A randomized placebo controlled trial assessing the efficacy and safety of etanercept in patients with idiopathic pulmonary fibrosis (IPF). Chest 128: 496S, 2005.
6. Hunninghake GW. Antioxidant therapy for idiopathic pulmonary fibrosis. N Engl J Med 353: 2285-2287, 2005.
7. Cantin AM, Hubbard RC, Crystal RG. Glutathione deficiency in the epithelial lining fluid of the lower respiratory tract in idiopathic pulmonary fibrosis. Am Rev Respir Dis 139: 370-372, 1989.
8. Behr J, Maier K, Degenkolb B, Krombach F, Vogelmeier C. Antioxidative and clinical effects of high-dose N-acetylcysteine in fibrosing alveolitis. Adjunctive therapy to maintenance immunosuppression. Am J Respir Crit Care Med 156: 1897-1901, 1997.
9. Collard HR, Moore BB, Flaherty KR, et al. Acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 176: 636-643, 2007.
10. Tomioka H, Kuwata Y, Imanaka K, et al. A pilot study of aerosolized N-acetylcysteine for idiopathic pulmonary fibrosis. Respirology 10: 449-455, 2005.
11. Yokoyama A, Kondo K, Nakajima M, et al. Prognostic value of circulating KL-6 in idiopathic pulmonary fibrosis. Respirology 11: 164-168, 2006.
12. King TE Jr, Behr J, Brown KK, et al. BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 177: 75-81, 2008.
13. King TE Jr, Albera C, Bradford WZ, et al. Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial. Lancet 374: 222-228, 2009.
14. Noble PW, Albera C, Bradford WZ, et al. Pirfenidone in the treatment of idiopathic pulmonary fibrosis: Results of two randomized, double-blind, placebo-controlled, phase III trials (The CAPACITY Trials). Am J Respir Crit Care Med 179: A1129, 2009.
15. Meyer AR, Buhl R, Magnussen H. The effect of oral Nacetylcysteine on lung glutathione levels in idiopathic pulmonary fibrosis. Eru Respir J 7: 431-436, 1994.
16. Martinez FJ, Safrin S, Weycker D, et al. The clinical course of patients with idiopathic pulmonary fibrosis. Ann Intern Med 142: 963-967, 2005.
17. Agarwal R, Jindal SK. Acute exacerbation of idiopathic pulmonary fibrosis: A systematic review. Eur J Inter Med 19: 227-235, 2008.